Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
IS13 - Industry Symposium Sponsored by Janssen Pharmaceuticals: Expanding Horizons for the Targeted Management of EGFR-Mutant NSCLC
- 13:15 - 14:15
- 8/07/2022
- Location: Strauss 3
- Not for CME Credit
- Type: Industry Symposium
- Track: N/A
-
+
IS13.03 - What's New in Molecular Diagnostics for EGFR-Mutant NSCLC?
13:25 - 13:32 | Presenter: Sabine Merkelbach-Bruse
- Abstract
Loading... -
+
IS13.04 - Novel Approaches in Treatment-Resistant Advanced EGFR-Mutant NSCLC
13:47 - 14:02 | Presenter: Sabine Merkelbach-Bruse
- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-031 - NRF2 Pathway Signature Predicts KEAP1/NFE2L2 Mutations and Reveals Alternative Pathway-Activating Mutations in NSCLC
Presenter: Christoph Arolt- Abstract
Loading... -
+
EP08.02-106 - KEAP1/NFE2L2 Transcriptomic Signature Predicts Survival in Advanced Stage NSCLC Patients Without Actionable Driver Mutations
Presenter: Matthias Scheffler- Abstract
Loading... -
+
EP08.02-114 - Comprehensive Analysis of ROS1 Aberrations without Rearrangements in Non-small cell Lung Cancer Patients
Presenter: Moritz Glaser- Abstract
Loading...
